[1] |
FLETCHER BR, DAMERY S, AIYEGBUSI OL, et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis[J]. PLoS Med, 2022, 19(4): e1003954. DOI: 10.1371/journal.pmed.1003954.
|
[2] |
THONGPRAYOON C, HANSRIVIJIT P, LEEAPHORN N, et al. Recent advances and clinical outcomes of kidney transplantation[J]. J Clin Med, 2020, 9(4): 1193. DOI: 10.3390/jcm9041193.
|
[3] |
LAI X, ZHENG X, MATHEW JM, et al. Tackling chronic kidney transplant rejection: challenges and promises[J]. Front Immunol, 2021, 12: 661643. DOI: 10.3389/fimmu.2021.661643.
|
[4] |
ORDIKHANI F, POTHULA V, SANCHEZ-TARJUELO R, et al. Macrophages in organ transplantation[J]. Front Immunol, 2020, 11: 582939. DOI: 10.3389/fimmu.2020.582939.
|
[5] |
WANG J, LUO P, ZHAO J, et al. Profiling the resident and infiltrating monocyte/macrophages during rejection following kidney transplantation[J]. J Immunol Res, 2020: 5746832. DOI: 10.1155/2020/5746832.
|
[6] |
LOCATI M, CURTALE G, MANTOVANI A. Diversity, mechanisms, and significance of macrophage plasticity[J]. Annu Rev Pathol, 2020, 15: 123-147. DOI: 10.1146/annurev-pathmechdis-012418-012718.
|
[7] |
DEVRAJ VM, KALIDINDI K, GUDITI S, et al. Macrophage polarization in kidney transplant patients[J]. Transpl Immunol, 2022, 75: 101717. DOI: 10.1016/j.trim.2022.101717.
|
[8] |
DOU M, DING C, ZHENG B, et al. Immune-related genes for predicting future kidney graft loss: a study based on GEO database[J]. Front Immunol, 2022, 13: 859693. DOI: 10.3389/fimmu.2022.859693.
|
[9] |
XU J, HU J, XU H, et al. Long non-coding RNA expression profiling in biopsy to identify renal allograft at risk of chronic damage and future graft loss[J]. Appl Biochem Biotechnol, 2020, 190(2): 660-673. DOI: 10.1007/s12010-019-03082-2.
|
[10] |
LIU S, WANG Z, ZHU R, et al. Three differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2[J]. J Vis Exp, 2021(175). DOI: 10.3791/62528.
|
[11] |
TIBSHIRANI R. The LASSO method for variable selection in the Cox model[J]. Stat Med, 1997, 16(4): 385-395.
|
[12] |
RU Y, KECHRIS KJ, TABAKOFF B, et al. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations[J]. Nucleic Acids Res, 2014, 42(17): e133. DOI: 10.1093/nar/gku631.
|
[13] |
ZHOU H, LU H, SUN L, et al. Diagnostic biomarkers and immune infiltration in patients with T cell-mediated rejection after kidney transplantation[J]. Front Immunol, 2022, 12: 774321. DOI: 10.3389/fimmu.2021.774321.
|
[14] |
SHEN Q, WANG Y, CHEN J, et al. Single-cell RNA sequencing reveals the immunological profiles of renal allograft rejection in mice[J]. Front Immunol, 2021, 12: 693608. DOI: 10.3389/fimmu.2021.693608.
|
[15] |
LU J, ZHANG Y, SUN J, et al. The immune cell landscape in renal allografts[J]. Cell Transplant, 2021, 30: 963689721995458. DOI: 10.1177/0963689721995458.
|
[16] |
HOLÁN V, KRULOVÁ M, ZAJÍCOVÁ A, et al. Nitric oxide as a regulatory and effector molecule in the immune system[J]. Mol Immunol, 2002, 38(12/13): 989-995. DOI: 10.1016/s0161-5890(02)00027-5.
|
[17] |
BRAZA F, BROUARD S, CHADBAN S, et al. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes[J]. Nat Rev Nephrol, 2016, 12(5): 281-290. DOI: 10.1038/nrneph.2016.41.
|
[18] |
DESSING MC, BEMELMAN FJ, CLAESSEN N, et al. Intragraft Toll-like receptor profiling in acute renal allograft rejection[J]. Nephrol Dial Transplant, 2010, 25(12): 4087-4092. DOI: 10.1093/ndt/gfq589.
|
[19] |
WANG N, LIANG H, ZEN K. Molecular mechanisms that influence the macrophage M1-M2 polarization balance[J]. Front Immunol, 2014, 5: 614. DOI: 10.3389/fimmu.2014.00614.
|
[20] |
VAN LOON E, GAZUT S, YAZDANI S, et al. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: a multicentre, prospective study[J]. EBioMedicine, 2019, 46: 463-472. DOI: 10.1016/j.ebiom.2019.07.028.
|
[21] |
TAN PS, GAVIN AL, BARNES N, et al. Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells[J]. J Immunol, 2003, 170(5): 2549-2556. DOI: 10.4049/jimmunol.170.5.2549.
|
[22] |
MANNAM VK, LEWIS RE, CRUSE JM. The fate of renal allografts hinges on responses of the microvascular endothelium[J]. Exp Mol Pathol, 2013, 94(2): 398-411. DOI: 10.1016/j.yexmp.2012.06.002.
|
[23] |
SHAATH H, VISHNUBALAJI R, ELKORD E, et al. Single-cell transcriptome analysis highlights a role for neutrophils and inflammatory macrophages in the pathogenesis of severe COVID-19[J]. Cells, 2020, 9(11): 2374. DOI: 10.3390/cells9112374.
|
[24] |
KUBO K, KAWATO Y, NAKAMURA K, et al. Effective suppression of donor specific antibody production by cathepsin S inhibitors in a mouse transplantation model[J]. Eur J Pharmacol, 2018, 838: 145-152. DOI: 10.1016/j.ejphar.2018.09.007.
|
[25] |
FUJⅡ H, IVISON SM, SHIMIZU H, et al. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens[J]. Biol Blood Marrow Transplant, 2012, 18(4): 546-556. DOI: 10.1016/j.bbmt.2011.11.027.
|
[26] |
HUGHES CS, COLHOUN LM, BAINS BK, et al. Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages[J]. Part Fibre Toxicol, 2016, 13: 19. DOI: 10.1186/s12989-016-0129-5.
|
[27] |
REEVE J, EINECKE G, MENGEL M, et al. Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches[J]. Am J Transplant, 2009, 9(8): 1802-1810. DOI: 10.1111/j.1600-6143.2009.02694.x.
|
[28] |
KOBAYASHI S, NAGANO H, MARUBASHI S, et al. Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection[J]. Transpl Int, 2010, 23(4): 390-396. DOI: 10.1111/j.1432-2277.2009.00991.x.
|
[29] |
LARA-REYNA S, CASELEY EA, TOPPING J, et al. Inflammasome activation: from molecular mechanisms to autoinflammation[J]. Clin Transl Immunology, 2022, 11(7): e1404. DOI: 10.1002/cti2.1404.
|
[30] |
KARASAWA T, KAWASHIMA A, USUI F, et al. Oligomerized CARD16 promotes Caspase-1 assembly and IL-1β processing[J]. FEBS Open Bio, 2015, 5: 348-356. DOI: 10.1016/j.fob.2015.04.011.
|
[31] |
NANKIVELL BJ, ALEXANDER SI. Rejection of the kidney allograft[J]. N Engl J Med, 2010, 363(15): 1451-1462. DOI: 10.1056/NEJMra0902927.
|
[32] |
KAMINSKI H, MARSÈRES G, COSENTINO A, et al. Understanding human γδ T cell biology toward a better management of cytomegalovirus infection[J]. Immunol Rev, 2020, 298(1): 264-288. DOI: 10.1111/imr.12922.
|
[33] |
KIRK AD, IBRAHIM S, DAWSON DV, et al. Characterization of T cells expressing the gamma/delta antigen receptor in human renal allografts[J]. Hum Immunol, 1993, 36(1): 11-19. DOI: 10.1016/0198-8859(93)90003-j.
|
[34] |
KAMINSKI H, GARRIGUE I, COUZI L, et al. Surveillance of γδ T cells predicts cytomegalovirus infection resolution in kidney transplants[J]. J Am Soc Nephrol, 2016, 27(2): 637-645. DOI: 10.1681/ASN.2014100985.
|
[35] |
BACHELET T, COUZI L, PITARD V, et al. Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions[J]. J Am Soc Nephrol, 2014, 25(11): 2471-2482. DOI: 10.1681/ASN.2013101052.
|
[36] |
JENKINS SJ, ALLEN JE. The expanding world of tissue-resident macrophages[J]. Eur J Immunol, 2021, 51(8): 1882-1896. DOI: 10.1002/eji.202048881.
|